I-PEN® Osmolarity System
I-PEN® Osmolarity System Now Available in Brazil Through Partnership with DryCom
March 26, 2019 13:42 ET | I-MED Pharma
MONTREAL, March 26, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with...
visiongain Logo 72dpi.jpg
Visiongain report says: Global Ophthalmic Drugs Market Set To Grow To $29bn By 2022
December 12, 2018 07:48 ET | Visiongain Ltd
LONDON, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Visiongain report says: Global Ophthalmic Drugs Market Set To Grow To $29bn By 2022. Visiongain has launched a new pharma report entitled Global...
I-MED Pharma présente la technologie éprouvée E>Eye IRPL® au Canada
May 24, 2018 13:36 ET | I-MED Pharma
MONTRÉAL, 24 mai 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, est ravie d’annoncer...
E-EYE in use
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
May 24, 2018 13:36 ET | I-MED Pharma
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of a Canadian distribution...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye Indications
March 21, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, March 21, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has retained the...
Parion Corporate Logo-01.png
Parion Sciences Announces Initiation of Phase 2 Clinical Trial of P-321 for the Treatment of Dry Eye Disease
July 26, 2016 07:59 ET | Parion Sciences
DURHAM, N.C,, July 26, 2016 (GLOBE NEWSWIRE) -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced today it has initiated a...
Parion Corporate Logo-01.png
Ceva and Zoion Pharma Announce Collaboration to Develop Epithelial Sodium Channel Blockers to Treat Veterinary Ocular Surface Diseases
January 19, 2016 08:00 ET | Parion Sciences
LIBOURNE, France and DURHAM, N.C., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Ceva Santé Animale and Zoion Pharma Inc. announced today that they have entered into a collaboration to develop an epithelial...
Parion Sciences Receives 2015 Life Sciences Award as “Best Late Stage Product Development” Company  
May 22, 2015 09:28 ET | Parion Sciences
DURHAM, N.C., May 22, 2015 (GLOBE NEWSWIRE) -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced today that it was awarded the...
Dry Eye Can Now Be T
Dry Eye Can Now Be Treated With IPL Therapy, Say Chester County Ophthalmologists
April 14, 2014 06:01 ET | Chester County Eye Care Associates
WEST CHESTER, PA--(Marketwired - Apr 14, 2014) - A recent study from Ophthalmology1 found Americans who live in cities with a high level of air pollution, including New York City, Chicago, and Los...
NVISION Laser Eye Centers Introduces Its First New Service Since Changing Its Name From TLC Laser Eye Centers
October 11, 2010 11:30 ET | NVISION Laser Eye Centers
NEWPORT BEACH, CA--(Marketwire - October 11, 2010) -  NVISION Laser Eye Centers, formerly part of TLC Laser Eye Centers, is introducing its first new service since changing its name last month. ...